At a glance
- Originator Kitasato Institute; Yamanouchi
- Class Cytostatic antibiotics; Lactones; Small molecules
- Mechanism of Action Protein 50S ribosomal subunit inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections; Cancer